Edwards Lifesciences Corp

EW-N

NYSE:EW

74.37
3.37 (4.75%)
Edwards Lifesciences is an American medical equipment company specializing in artificial heart valves and hemodynamic monitoring.
More at Wikipedia

Analysis and Opinions about EW-N

Signal
Opinion
Expert
COMMENT
COMMENT
August 6, 2019

He has owned IRTC-O in the past. It is in the medical device space and has equipment that looks for heart arrhythmia and loads the data to the cloud. The market has not yet said this stock has taken a positive turn yet. Earnings are growing and it is growing into its share price. He wants to see it break above $85-$87 before getting back in. He would prefer holding EW-N

Show full opinionHide full opinion

He has owned IRTC-O in the past. It is in the medical device space and has equipment that looks for heart arrhythmia and loads the data to the cloud. The market has not yet said this stock has taken a positive turn yet. Earnings are growing and it is growing into its share price. He wants to see it break above $85-$87 before getting back in. He would prefer holding EW-N

PAST TOP PICK
PAST TOP PICK
March 6, 2019
(A Top Pick Mar 19/18, Up 22%) He owns this through the IHI ETF. Their catheter device accounts for 60% of revenue and results in less-invasive surgeries which results in higher patient turnover in hospitals (which are expensive). This is better for patients and hospitals. They continue to take market share.
Show full opinionHide full opinion
(A Top Pick Mar 19/18, Up 22%) He owns this through the IHI ETF. Their catheter device accounts for 60% of revenue and results in less-invasive surgeries which results in higher patient turnover in hospitals (which are expensive). This is better for patients and hospitals. They continue to take market share.
PAST TOP PICK
PAST TOP PICK
February 6, 2019
(A Top Pick Feb 08/18, Up 37%) A high-quality holding, who's business is less evasive surgery technology. They have massive market share in the space. Lots of spending by hospitals will go into this. You have to accept it will be volatile at times.
Show full opinionHide full opinion
(A Top Pick Feb 08/18, Up 37%) A high-quality holding, who's business is less evasive surgery technology. They have massive market share in the space. Lots of spending by hospitals will go into this. You have to accept it will be volatile at times.
DON'T BUY
DON'T BUY
August 30, 2018

When it came down to his model price it was the only buying opportunity there was in the last eight years. He loves the company. Model price is $99.94, a 30% premium that it is trading at. He can only wish for a pull back.

Show full opinionHide full opinion

When it came down to his model price it was the only buying opportunity there was in the last eight years. He loves the company. Model price is $99.94, a 30% premium that it is trading at. He can only wish for a pull back.

TOP PICK
TOP PICK
March 19, 2018

Trans-catheter aortic valve replacement is their business, a best in class valve that's been taken up widely in hospitals around the world. This market will double in three years, and they are the big player. (Analysts' target of $142.80)

Show full opinionHide full opinion

Trans-catheter aortic valve replacement is their business, a best in class valve that's been taken up widely in hospitals around the world. This market will double in three years, and they are the big player. (Analysts' target of $142.80)

TOP PICK
TOP PICK
February 8, 2018

Valve replacement. They have trans catheter valve replacements. It is done in the least invasive way that the medical space has come up with. It is all very positive. They are well placed in a growing part of the healthcare market. It is expected to double by 2021. (Analysts’ target: $142.).

Show full opinionHide full opinion

Valve replacement. They have trans catheter valve replacements. It is done in the least invasive way that the medical space has come up with. It is all very positive. They are well placed in a growing part of the healthcare market. It is expected to double by 2021. (Analysts’ target: $142.).

COMMENT
COMMENT
January 25, 2017

Very focused on cardiovascular and ICU. The great thing about this is that the demand is very inelastic, so you get the unit demand independent of the economic cycle, a good solid demand. Also, they are innovators and have good research and good product flow on their own and have been smart acquirers.

Show full opinionHide full opinion

Very focused on cardiovascular and ICU. The great thing about this is that the demand is very inelastic, so you get the unit demand independent of the economic cycle, a good solid demand. Also, they are innovators and have good research and good product flow on their own and have been smart acquirers.

TOP PICK
TOP PICK
July 6, 2005
Primarily involved in cardiovascular products. Half the business is in heart valve therapy with about 45% of market share. Have some new products that could create new markets for them and this hasn't been priced into the stock.
Show full opinionHide full opinion
Primarily involved in cardiovascular products. Half the business is in heart valve therapy with about 45% of market share. Have some new products that could create new markets for them and this hasn't been priced into the stock.
Showing 1 to 8 of 8 entries
  • «
  • 1
  • »

Edwards Lifesciences Corp(EW-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Edwards Lifesciences Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Edwards Lifesciences Corp(EW-N) Frequently Asked Questions

What is Edwards Lifesciences Corp stock symbol?

Edwards Lifesciences Corp is a American stock, trading under the symbol EW-N on the New York Stock Exchange (EW). It is usually referred to as NYSE:EW or EW-N

Is Edwards Lifesciences Corp a buy or a sell?

In the last year, there was no coverage of Edwards Lifesciences Corp published on Stockchase.

Is Edwards Lifesciences Corp a good investment or a top pick?

Edwards Lifesciences Corp was recommended as a Top Pick by David Burrows on 2019-08-06. Read the latest stock experts ratings for Edwards Lifesciences Corp.

Why is Edwards Lifesciences Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Edwards Lifesciences Corp worth watching?

In the last year, there was no coverage of Edwards Lifesciences Corp published on Stockchase.

What is Edwards Lifesciences Corp stock price?

On 2020-06-05, Edwards Lifesciences Corp (EW-N) stock closed at a price of $74.37.